文献速递MDS 与骨髓增殖性肿瘤

长链非编码RNA KIAA0125表达水平与骨髓增生异常综合征临床及生物学特征相关

The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes.
PubMed 文献 · Br J Haematol · 2020-11-29

该研究采用RNA芯片检测176例原发MDS患者KIAA0125表达,发现高表达与更高危IPSS-R分层、ASXL1及NRAS突变相关,并预示更差OS和LFS;多因素分析显示其为独立不良预后因素,且与白血病干细胞特征相关。

要点

  • KIAA0125高表达与高危MDS、ASXL1/NRAS突变及更差OS/LFS相关。
  • KIAA0125高表达是OS和LFS的独立不良预后因素,不受IPSS-R和突变状态影响。
  • KIAA0125表达可能与白血病干细胞特征相关,或可指导MDS治疗选择。

核心结论

  • KIAA0125高表达是MDS患者OS和LFS的独立不良预后因素,且与高危临床生物学特征及白血病干细胞特征相关。

研究设计与样本

  • 研究采用RNA芯片检测176例原发MDS患者KIAA0125表达水平,并分析其与临床特征、突变及预后的关系。

主要发现

  • KIAA0125高表达与基于IPSS-R的更高危MDS、ASXL1和NRAS突变相关。
  • KIAA0125高表达预示更差的总生存(OS)和无白血病生存(LFS)。
  • 多因素分析显示KIAA0125高表达是OS和LFS的独立不良预后因素,不受IPSS-R和突变状态影响。
  • 全局基因表达谱分析提示KIAA0125高表达与白血病干细胞特征密切相关。

临床怎么用

  • KIAA0125表达水平可能作为生物标志物,辅助MDS患者的治疗选择,尤其适用于通常接受姑息治疗的低危亚型患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Long non-coding RNAs (lncRNAs) have important functions in cancer biology. Among them, lncRNA KIAA0125 is one of the genes proposed to play a critical role in leukaemia stem cell (LSC). In this study, we aimed to investigate the clinical relevance of the expression levels of lncRNA KIAA0125 in myelodysplastic syndromes (MDS), a disease with highly heterogeneous clinical and biological features. Using RNA arrays, we measured the expression of KIAA0125 in 176 primary MDS patients. We found that higher KIAA0125 expression was associated with higher risk MDS, based on the revised International Prognostic Scoring System (IPSS-R), mutations in ASXL1 and NRAS, and predicted poorer overall survival (OS) and leukaemia-free survival (LFS). Multivariate analysis revealed that higher KIAA0125 expression was an independent, unfavourable prognostic factor for OS and LFS, irrespective of IPSS-R and mutation status. Further global gene expression profile analysis suggested a close association of higher KIAA0125 expressions with LSC signatures. The expression of KIAA0125 may be a potential biomarker to guide the treatment choice in MDS patients, especially those with lower risk subtypes, in whom palliative treatment is usually used.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Hung SY, Lin CC, Hsu CL, et al. The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes. Br J Haematol. 2020. PMID: 33249572. doi:10.1111/bjh.17231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。